Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity

References

• International Committee for the Classification of Retinopathy of PrematurityThe international classification of retinopathy of prematurity revisitedArch Ophthalmol2005123799199916009843
   PubMed Web of Science ®Google Scholar
• KychenthalADortaPKatzXZone I retinopathy of prematurity: clinical characteristics and treatment outcomesRetina2006267 supplS11S1516946670
   PubMed Web of Science ®Google Scholar
• YokoiTHiraokaMMiyamotoMVascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiographyOphthalmology200911671377138219481811
   PubMed Web of Science ®Google Scholar
• SanghiGDograMRDasPVinekarAGuptaADuttaSAggressive posterior retinopathy of prematurity in Asian Indian babies: spectrum of disease and outcome after laser treatmentRetina20092991335133919574949
   PubMed Web of Science ®Google Scholar
• Multicenter trial of cryotherapy for retinopathy of prematurityPreliminary results. Cryotherapy for retinopathy of prematurity cooperative groupArch Ophthalmol198810644714792895630
   PubMed Web of Science ®Google Scholar
• FielderARPreliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trialArch Ophthalmol2003121121769177114662598
   PubMedGoogle Scholar
• FlynnJTChan-LingTRetinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 diseaseAm J Ophthalmol20061421465916815250
   PubMed Web of Science ®Google Scholar
• O’KeefeMLaniganBLongVWOutcome of zone 1 retinopathy of prematurityActa Ophthalmol Scand200381661461614641264
   PubMedGoogle Scholar
• KatzXKychenthalADortaPZone I retinopathy of prematurityJ AAPOS20004637337611124674
   PubMed Web of Science ®Google Scholar
• SanghiGDograMRKatochDGuptaAAggressive posterior retinopathy of prematurity: risk factors for retinal detachment despite confluent laser photocoagulationAm J Ophthalmol2013155115916423022161
   PubMed Web of Science ®Google Scholar
• DrenserKATreseMTCaponeAJrAggressive posterior retinopathy of prematurityRetina2010304 supplS37S4020224476
   PubMedGoogle Scholar
• ChenJSmithLERetinopathy of prematurityAngiogenesis200710213314017332988
   PubMedGoogle Scholar
• HellstromAPerruzziCJuMLow IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurityProc Natl Acad Sci U S A200198105804580811331770
   PubMed Web of Science ®Google Scholar
• SmithLEPathogenesis of retinopathy of prematurityGrowth Horm IGF Res200414suppl AS140S14415135797
   PubMed Web of Science ®Google Scholar
• SmithLEPathogenesis of retinopathy of prematurityActa Paediatr Suppl200291437262812200894
   PubMedGoogle Scholar
• TravassosATeixeiraSFerreiraPIntravitreal bevacizumab in aggressive posterior retinopathy of prematurityOphthalmic Surg Lasers Imaging200738323323717552391
   PubMedGoogle Scholar
• SangtamTVinekarAMaheshwarBDograMREongKGIntravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurityIndian J Ophthalmol200755431731817595489
   PubMedGoogle Scholar
• ChungEJKimJHAhnHSKohHJCombination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurityGraefes Arch Clin Exp Ophthalmol2007245111727173017690897
   PubMed Web of Science ®Google Scholar
• HondaSHirabayashiHTsukaharaYNegiAAcute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurityGraefes Arch Clin Exp Ophthalmol200824671061106318320201
   PubMed Web of Science ®Google Scholar
• HosseiniHKhaliliMRNowroozizadehSIntravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone IIRetina200929456256419262431
   PubMed Web of Science ®Google Scholar
• Mintz-HittnerHAKennedyKAChuangAZEfficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurityN Engl J Med2011364760361521323540
   PubMed Web of Science ®Google Scholar
• ChenSNLianIHwangYCIntravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between ranibizumab and bevacizumabRetina201535466767425462435
   PubMed Web of Science ®Google Scholar
• Orozco-GómezLPHernández-SalazarLMoguel-AncheitaSRamírez-MorenoMAMorales-CruzMVLaser-ranibizumab treatment for retinopathy of prematurity in umbral-preumbral disease. Three years of experienceCir Cir201179320721422380989
   PubMed Web of Science ®Google Scholar
• ZouLLaiHZhouQXiaoFLasting controversy on ranibizumab and bevacizumabTheranostics2011139540222211145
   PubMed Web of Science ®Google Scholar
• SchlachetzkiFZhuCPardridgeWMExpression of the neonatal Fc receptor (FcRn) at the blood-brain barrierJ Neurochem200281120320612067234
   PubMed Web of Science ®Google Scholar
• KimHRobinsonSBCsakyKGFcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eyeMol Vis2009152803281220019892
   PubMed Web of Science ®Google Scholar
• SatoTWadaKArahoriHSerum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurityAm J Ophthalmol2012153232733321930258
   PubMed Web of Science ®Google Scholar
• BakriSJSnyderMRReidJMPulidoJSSinghRJPharmacokinetics of intravitreal bevacizumab (Avastin)Ophthalmology2007114585585917467524
   PubMed Web of Science ®Google Scholar
• BakriSJSnyderMRReidJMPulidoJSEzzatMKSinghRJPharmacokinetics of intravitreal ranibizumab (Lucentis)Ophthalmology2007114122179218218054637
   PubMed Web of Science ®Google Scholar
• CarrionJZFortes FilhoJBTartarellaMBZinAJornada JrIDPrevalence of retinopathy of prematurity in Latin AmericaClin Ophthalmol201151687169522174577
   PubMedGoogle Scholar
• Fortes FilhoJBEckertGUValiattiFBDos SantosPGda CostaMCProcianoyRSThe influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP)Graefes Arch Clin Exp Ophthalmol2010248689390020016911
   PubMed Web of Science ®Google Scholar
• Fortes FilhoJBEckertGUValiattiFBSantosPGCostaMCProcianoyRSPostconceptional age at the treatment of retinopathy of prematurity in inborn and referred preterm infants from the same institutionArq Bras Oftalmol201174425125422068850
   PubMed Web of Science ®Google Scholar
• Early Treatment For Retinopathy Of Prematurity Cooperative GroupRevised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trialArch Ophthalmol2003121121684169414662586
   PubMedGoogle Scholar
• DaniCFrosiniSFortunatoPIntravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case seriesJ Matern Fetal Neonatal Med201225112194219722506618
   PubMed Web of Science ®Google Scholar
• HardALHellstromAOn the use of antiangiogenetic medications for retinopathy of prematurityActa Paediatr201110081063106521517962
   PubMed Web of Science ®Google Scholar
• SpandauUTomicZEwaldULarssonEAkerblomHHolmströmGTime to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?Acta Ophthalmol201391217017522268644
   PubMed Web of Science ®Google Scholar
• CarneiroAMCostaRFalcãoMSVascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumabActa Ophthalmol2012901e25e3021958440
   PubMed Web of Science ®Google Scholar
• HoersterRMuetherPDahlkeCSerum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurityActa Ophthalmol2013911e74e7522672259
   PubMed Web of Science ®Google Scholar
• WongRHubschmanSTsuiIReactivation of retinopathy of prematurity after ranibizumab treatmentRetina20153567568025768252
   PubMed Web of Science ®Google Scholar
• KrohneTZengpingLHolzFMeyerCIntrocular pharmakinetics of ranibizumab following a single intravitreal injection in humansAm J Ophthalmol201215468268622818800
   PubMed Web of Science ®Google Scholar
• ZhouYJiangYBaiYWenJChenLVascular endothelial growth factor plasma levels before an after treatment of retinopathy of prematurity with ranibizumabGraefes Arch Clin Exp Ophthalmol Epub201549
   Web of Science ®Google Scholar
• CastellanosMASchwartzSGarcía-AguirreGQuiroz-MercadoHShort-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurityBr J Ophthalmol201397781681923221964
   PubMed Web of Science ®Google Scholar
• LinCChenSChangYFengJEffects of ranibizumab on very low birth weight infants with stage 3 retinopathy of prematuityTaiwan J Ophthalmol20122136139
   Google Scholar
• TahijaSHersetyatiRLamGKusakaSMcMenaminPGFluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurityBr J Ophthalmol20149850751224403566
   PubMed Web of Science ®Google Scholar